| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $1.7B | $1.6B | $1.5B | $0.4B | $1.3B | $0.3B | $0.3B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.5B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.6B | $0.7B | $0.8B | $0.7B | $0.5B | $0.4B |
| Net Income | $0.5B | $0.5B | $0.5B | $0.1B | $0.7B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $3.11 | $3.34 | $3.59 | $0.82 | $4.01 | $0.70 | $0.74 | $0.58 |
| EPS (Diluted) | $3.07 | $3.27 | $3.52 | $0.82 | $3.93 | $0.68 | $0.73 | $0.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.5B | $10.4B | $9.9B | $8.3B | $8.1B | $7.8B | $7.0B | $5.5B |
| Current Assets | $2.3B | $2.6B | $1.8B | $2.0B | $1.9B | $1.9B | $2.2B | $2.5B |
| Cash & Equivalents | $0.9B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $1.0B |
| Total Liabilities | $6.5B | $5.5B | $5.3B | $3.9B | $3.6B | $3.5B | $3.3B | $2.3B |
| Current Liabilities | $1.0B | $2.1B | $0.8B | $0.8B | $0.8B | $0.8B | $0.7B | $1.2B |
| Stockholders' Equity | $5.0B | $4.9B | $4.6B | $4.4B | $4.5B | $4.3B | $3.7B | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.5B | $1.3B | $1.3B | $1.4B | $1.2B | $1.1B | $1.0B |
| Investing Cash Flow | $-0.5B | $-0.8B | $-1.8B | $-0.6B | $-0.6B | $-1.0B | $-1.7B | $-0.5B |
| Capital Expenditures | $0.5B | $0.4B | $0.5B | $0.2B | $0.3B | $0.5B | $0.4B | $0.2B |
| Financing Cash Flow | $-0.6B | $-0.7B | $0.4B | $-0.6B | $-0.6B | $-0.2B | $-0.0B | $0.2B |